A new UK clinical trial is testing repurposed diabetes and ADHD medicines to treat Alzheimer’s disease, aiming to speed up the discovery of effective treatments.
A government review in England warns that rising diagnosis rates for ADHD and autism may exceed expected population levels, urging reforms to support systems and private assessment regulations.
